» Articles » PMID: 32660781

The Introduction of a Super-urgent Heart Allocation Scheme in the UK: A 2-year Review

Overview
Publisher Elsevier
Date 2020 Jul 15
PMID 32660781
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In response to a growing number of patients on the UK urgent heart transplant waiting list, the UK donor heart allocation scheme was revised in October 2016 with the introduction of a new super-urgent category. Patients with temporary mechanical circulatory support (tMCS) became eligible for super-urgent registration. The aim of this study was to compare activity, indications, and outcomes before and after the change.

Methods: Data on adult (aged ≥16 years) heart transplant registrations and recipients in the 2 years before (Era 1: July 1, 2014-June 30, 2016) and after (Era 2: January 2017-December 2018) the introduction of the new scheme were extracted from the UK Transplant Registry and analyzed using competing risks analysis, Kaplan-Meier analysis, and Cox proportional-hazards regression.

Results: There were 525 waiting-list registrations in Era 1 and 594 in Era 2, including 14% super-urgent registrations, with 90% having some form of tMCS. Median waiting time to transplant was 41 days for all urgent registrations in Era 1 compared with 17 days for super-urgent registrations and 71 days for urgent registrations in Era 2. Numbers of non-urgent transplants were not affected. Deaths on the waiting list significantly decreased from 5% to 2% at 6 months between Era 1 and Era 2 (adjusted hazard ratio = 0.29, 95% CI = 0.13-0.62). In addition, total number of patients with tMCS were not different between both eras, suggesting no significant change in this area of clinical decision making. Post-transplant survival at 1 year for super-urgent recipients was not significantly different from post-transplant survival at 1 year for other categories.

Conclusions: The Introduction of a super-urgent heart allocation scheme in the UK reduces waiting time to transplant for the sickest patients, with comparable post-transplant survival while reducing deaths on the waiting list.

Citing Articles

Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant-Change of Paradigm.

Sipus D, Krzelj K, duric Z, Gasparovic H, Milicic D, Separovic Hanzevacki J J Clin Med. 2022; 11(23).

PMID: 36498676 PMC: 9736223. DOI: 10.3390/jcm11237101.


Extracorporeal Photopheresis With Low-Dose Immunosuppression in High-Risk Heart Transplant Patients-A Pilot Study.

Gokler J, Aliabadi-Zuckermann A, Zuckermann A, Osorio E, Knobler R, Moayedifar R Transpl Int. 2022; 35:10320.

PMID: 35401042 PMC: 8983826. DOI: 10.3389/ti.2022.10320.


Mechanical ventilation at the time of heart transplantation and associations with clinical outcomes.

Miller P, Mullan C, Chouairi F, Sen S, Clark K, Reinhardt S Eur Heart J Acute Cardiovasc Care. 2021; 10(8):843-851.

PMID: 34389855 PMC: 8557439. DOI: 10.1093/ehjacc/zuab063.